GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » EV-to-FCF

ANG Lifesciences India (BOM:540694) EV-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ANG Lifesciences India's Enterprise Value is ₹1,212 Mil. ANG Lifesciences India's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil. Therefore, ANG Lifesciences India's EV-to-FCF for today is .

The historical rank and industry rank for ANG Lifesciences India's EV-to-FCF or its related term are showing as below:

BOM:540694' s EV-to-FCF Range Over the Past 10 Years
Min: -4.72   Med: 12.16   Max: 162.5
Current: 7.56

During the past 11 years, the highest EV-to-FCF of ANG Lifesciences India was 162.50. The lowest was -4.72. And the median was 12.16.

BOM:540694's EV-to-FCF is ranked better than
85.82% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23 vs BOM:540694: 7.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), ANG Lifesciences India's stock price is ₹52.54. ANG Lifesciences India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-9.042. Therefore, ANG Lifesciences India's PE Ratio for today is At Loss.


ANG Lifesciences India EV-to-FCF Historical Data

The historical data trend for ANG Lifesciences India's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India EV-to-FCF Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.10 11.17 17.86 -18.86 10.41

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.41 - - -

Competitive Comparison of ANG Lifesciences India's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's EV-to-FCF falls into.



ANG Lifesciences India EV-to-FCF Calculation

ANG Lifesciences India's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1211.817/0
=

ANG Lifesciences India's current Enterprise Value is ₹1,212 Mil.
ANG Lifesciences India's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India  (BOM:540694) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ANG Lifesciences India's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.54/-9.042
=At Loss

ANG Lifesciences India's share price for today is ₹52.54.
ANG Lifesciences India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-9.042.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ANG Lifesciences India EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines